Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes - PubMed (original) (raw)
Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes
E Apolloni et al. J Immunol. 2000.
Abstract
We described a generalized suppression of CTL anamnestic responses that occurred in mice bearing large tumor nodules or immunized with powerful recombinant viral immunogens. Immune suppression entirely depended on GM-CSF-driven accumulation of CD11b(+)/Gr-1(+) myeloid suppressor cells (MSC) in secondary lymphoid organs. To further investigate the nature and properties of MSC, we immortalized CD11b(+)/Gr-1(+) cells isolated from the spleens of immunosuppressed mice, using a retrovirus encoding the v-myc and v-raf oncogenes. Immortalized cells expressed monocyte/macrophage markers (CD11b, F4/80, CD86, CD11c), but they differed from previously characterized macrophage lines in their capacities to inhibit T lymphocyte activation. Two MSC lines, MSC-1 and MSC-2, were selected based upon their abilities to inhibit Ag-specific proliferative and functional CTL responses. MSC-1 line was constitutively inhibitory, while suppressive functions of MSC-2 line were stimulated by exposure to the cytokine IL-4. Both MSC lines triggered the apoptotic cascade in Ag-activated T lymphocytes by a mechanism requiring cell-cell contact. Some well-known membrane molecules involved in the activation of apoptotic pathways (e.g., TNF-related apoptosis-inducing ligand, Fas ligand, TNF-alpha) were ruled out as candidate effectors for the suppression mechanism. The immortalized myeloid lines represent a novel, useful tool to shed light on the molecules involved in the differentiation of myeloid-related suppressors as well as in the inhibitory pathway they use to control T lymphocyte activation.
Similar articles
- Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.
Mazzoni A, Bronte V, Visintin A, Spitzer JH, Apolloni E, Serafini P, Zanovello P, Segal DM. Mazzoni A, et al. J Immunol. 2002 Jan 15;168(2):689-95. doi: 10.4049/jimmunol.168.2.689. J Immunol. 2002. PMID: 11777962 - Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N, Brooks AD, Carter CR, Back TC, Parsoneault EM, Smyth MJ, Wiltrout RH, Sayers TJ. Seki N, et al. J Immunol. 2002 Apr 1;168(7):3484-92. doi: 10.4049/jimmunol.168.7.3484. J Immunol. 2002. PMID: 11907109 - TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages.
Kaplan MJ, Ray D, Mo RR, Yung RL, Richardson BC. Kaplan MJ, et al. J Immunol. 2000 Mar 15;164(6):2897-904. doi: 10.4049/jimmunol.164.6.2897. J Immunol. 2000. PMID: 10706675 - Fas-induced apoptosis.
Nagata S. Nagata S. Intern Med. 1998 Feb;37(2):179-81. doi: 10.2169/internalmedicine.37.179. Intern Med. 1998. PMID: 9550601 Review. No abstract available. - Effector lymphocytes in autoimmunity.
Santamaria P. Santamaria P. Curr Opin Immunol. 2001 Dec;13(6):663-9. doi: 10.1016/s0952-7915(01)00276-x. Curr Opin Immunol. 2001. PMID: 11677087 Review.
Cited by
- Targeting Myeloid-Derived Suppressor Cells via Dual-Antibody Fluorescent Nanodiamond Conjugate.
Angell CD, Lapurga G, Sun SH, Johnson C, Savardekar H, Rampersaud IV, Fletcher C, Albertson D, Ren C, Suarez-Kelly LP, Rampersaud AA, Carson WE 3rd. Angell CD, et al. Nanomaterials (Basel). 2024 Sep 17;14(18):1509. doi: 10.3390/nano14181509. Nanomaterials (Basel). 2024. PMID: 39330666 Free PMC article. - BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy.
Sun SH, Angell CD, Savardekar H, Sundi D, Abood D, Benner B, DiVincenzo MJ, Duggan M, Choueiry F, Mace T, Trikha P, Lapurga G, Johnson C, Carlson EJ, Chung C, Peterson BR, Lianbo Yu, Zhao J, Kendra KL, Carson WE 3rd. Sun SH, et al. Cancer Immunol Immunother. 2023 Nov;72(11):3461-3474. doi: 10.1007/s00262-023-03497-1. Epub 2023 Aug 2. Cancer Immunol Immunother. 2023. PMID: 37528320 Free PMC article. - Fluorescent Detection of Peroxynitrite Produced by Myeloid-Derived Suppressor Cells in Cancer and Inhibition by Dasatinib.
Carlson EJ, Savardekar H, Hu X, Lapurga G, Johnson C, Sun SH, Carson WE, Peterson BR. Carlson EJ, et al. ACS Pharmacol Transl Sci. 2023 May 2;6(5):738-747. doi: 10.1021/acsptsci.3c00014. eCollection 2023 May 12. ACS Pharmacol Transl Sci. 2023. PMID: 37200815 Free PMC article. - Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy.
Wu Y, Yi M, Niu M, Mei Q, Wu K. Wu Y, et al. Mol Cancer. 2022 Sep 26;21(1):184. doi: 10.1186/s12943-022-01657-y. Mol Cancer. 2022. PMID: 36163047 Free PMC article. Review. - Ligustilide Inhibits Tumor Angiogenesis by Downregulating VEGFA Secretion from Cancer-Associated Fibroblasts in Prostate Cancer via TLR4.
Ma J, Chen X, Chen Y, Tao N, Qin Z. Ma J, et al. Cancers (Basel). 2022 May 13;14(10):2406. doi: 10.3390/cancers14102406. Cancers (Basel). 2022. PMID: 35626012 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous